Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
This study has been withdrawn prior to enrollment.
(Study drug supplier withdrew support for the study. Study was withdrawn from the Duke IRB.)
Information provided by (Responsible Party):
Annick Desjardins, Duke University Medical Center
First received: May 4, 2008
Last updated: November 20, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||June 2012|
|Estimated Primary Completion Date:||June 2010 (Final data collection date for primary outcome measure)|